Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
307 artigos
Engineered immune cells offer new hope for treating kidney diseases that resist standard therapies, potentially improving long-term health outcomes.
Combining targeted therapies may help patients with severe hidradenitis suppurativa who don't respond to standard treatments.
New targeted therapies and biomarker-driven approaches are revolutionizing RA management, potentially improving healthspan for millions.
New research reveals how rheumatoid arthritis dramatically increases kidney disease risk through inflammation and medication effects.
New research reveals how KLF2 and KLF3 proteins regulate T cell movement and exhaustion, offering insights for immune system optimization.
New research reveals how tissue fibroblasts orchestrate age-related inflammation, creating exhausted T cells that increase vulnerability to disease.
New research reveals how specialized gut cells maintain protective immunity against parasites, offering insights into immune system optimization.
Women with RA using treat-to-target therapy achieved pregnancy 3x faster than those with standard care, with 77% conceiving within one year.
New research reveals gait retraining may improve overall posture and movement patterns, not just knee function.
New research explores how pregnancy affects rheumatoid arthritis symptoms and long-term health outcomes for women.
New research reveals how changing walking patterns can enhance overall body alignment and movement quality for better long-term health.
Combining ixekizumab with tirzepatide achieved better joint health and significant weight loss compared to arthritis treatment alone.
